The pharmacological basis of anti-IgE therapy
Article Abstract:
Unique, humanized anti-IgE monoclonal antibodies are found to be useful in the treatment of asthma and allergic rhinitis according to the results of multiple phase II and III human clinical studies.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
CD18 trials disappoint again
Article Abstract:
Genentech's anti-CD18 monoclonal antibodies, designed for use in treating heart attacks, perform poorly in a phase II trial, failing to improve blood flow within the 90 minute target range.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Growing pains for biopharmaceuticals. Biopharmaceuticals have provided a swift means of swelling pharmaceutical company pipelines, but they may not be such a fast "fix" for the industry in the future
Article Abstract:
This study examines the economic contribution of biotechnology (recombinant proteins, and monoclonal antibodies) and its impact upon drug development, and the pharmaceutical industry as a whole for the years 1982 through 2000.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Tumor angiogenesis-new drugs on the block: angeogenisis inhibitors could represent adjunct to traditional cancer treatments, but the most effective routes for therapeutic intervention remain unclear
- Abstracts: Super-wide-format inkjet printers offer consistency plus versatility. Microsoft's new Windows Me is game for the joystick